作者
Dennis Odera,James Tuju,Kennedy Mwai,Irene Nkumama,Kristin Fürle,Timothy Chege,Rinter Kimathi,Stefan Diehl,Fauzia Musasia,M Rosenkranz,Patricia Njuguna,Mainga Hamaluba,Melissa Kapulu,Roland Frank,Faith Osier,Abdirahman Abdi,Primus Che,Zaydah R. de Laurent,Irene Jao,Dorcas Kamuya,Gathoni Kamuyu,Johnstone Makale,Linda M. Murungi,Jennifer Musyoki,Michelle Muthui,Jedidah Mwacharo,Silvia N. Kariuki,Daniel Mwanga,Joyce Mwongeli,Francis M. Ndungu,Maureen Njue,George Nyangweso,Domitila Kimani,Joyce M. Ngoi,Janet Musembi,Omar Ngoto,Edward Otieno,Michael Ooko,Jimmy Shangala,Juliana Wambua,Khadija Said Mohammed,Donwilliams O. Omuoyo,Moses Mosobo,Nelson Kibinge,Sam Kinyanjui,Philip Bejon,Brett Lowe,Kevin Marsh,Vicki Marsh,Yonas Abebe,Peter F. Billingsley,B. Kim Lee Sim,Stephen L. Hoffman,Eric R. James,Thomas L. Richie,Agnes Audi,Fredrick Olewe,James Alan Oloo,John Michael Ong’echa,Martin O. Ongas,Nelly Koskei,Peter C. Bull,Susanne H. Hodgson,Cheryl Andisi Kivisi,Mallika Imwong,Sean C. Murphy,Bernhards Ogutu,Joel Tärning,Markus Winterberg,Thomas N. Williams
摘要
Natural killer (NK) cells are potent immune effectors that can be activated via antibody-mediated Fc receptor engagement. Using multiparameter flow cytometry, we found that NK cells degranulate and release IFN-γ upon stimulation with antibody-opsonized Plasmodium falciparum merozoites. Antibody-dependent NK (Ab-NK) activity was largely strain transcending and enhanced invasion inhibition into erythrocytes. Ab-NK was associated with the successful control of parasitemia after experimental malaria challenge in African adults. In an independent cohort study in children, Ab-NK increased with age, was boosted by concurrent P. falciparum infections, and was associated with a lower risk of clinical episodes of malaria. Nine of the 14 vaccine candidates tested induced Ab-NK, including some less well-characterized antigens: P41, P113, MSP11, RHOPH3, and Pf_11363200. These data highlight an important role of Ab-NK activity in immunity against malaria and provide a potential mechanism for evaluating vaccine candidates.